Meso Emerging Active

Aktis Oncology: sağlık hisselerinde içeriden alım

New narrative with limited coverage — still forming.

Puan
0,5
Hız
▲ 1,0
Makaleler
1
Kaynaklar
1

Sentiment Timeline

Event Timeline

Nis 12, 2026
H.C. Wainwright Raises its Price Target on Aktis Oncology (AKTS) to $33 Neutral

İlgili Makaleler

H.C. Wainwright Raises its Price Target on Aktis Oncology (AKTS) to $33

Yahoo Finance · Nis 12, 2026
Mixed

Zaman Çizelgesi

Son GüncellemeNis 12, 2026